Emergent BioSolutions Files 8-K
Ticker: EBS · Form: 8-K · Filed: Mar 31, 2025 · CIK: 1367644
| Field | Detail |
|---|---|
| Company | Emergent Biosolutions Inc. (EBS) |
| Form Type | 8-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing, financials
TL;DR
Emergent BioSolutions filed an 8-K on 3/31/25. Standard reporting.
AI Summary
Emergent BioSolutions Inc. filed an 8-K on March 31, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing details the company's principal executive offices located at 300 Professional Drive, Gaithersburg, Maryland, and its primary business in Pharmaceutical Preparations.
Why It Matters
This filing provides an update on Emergent BioSolutions' corporate activities and financial reporting, which is important for investors to monitor the company's status.
Risk Assessment
Risk Level: low — This filing appears to be a routine disclosure of corporate information and financial statements, not indicating any immediate significant risks.
Key Players & Entities
- Emergent BioSolutions Inc. (company) — Registrant
- March 31, 2025 (date) — Date of earliest event reported
- 300 Professional Drive, Gaithersburg, Maryland 20879 (location) — Principal executive offices
- 2834 (industry_code) — Standard Industrial Classification (Pharmaceutical Preparations)
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is primarily to report "Other Events" and "Financial Statements and Exhibits" as of March 31, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on March 31, 2025.
Where are Emergent BioSolutions Inc.'s principal executive offices located?
Emergent BioSolutions Inc.'s principal executive offices are located at 300 Professional Drive, Gaithersburg, Maryland 20879.
What is Emergent BioSolutions Inc.'s Standard Industrial Classification code?
Emergent BioSolutions Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
What is the SEC file number for Emergent BioSolutions Inc.?
The SEC file number for Emergent BioSolutions Inc. is 001-33137.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 31, 2025 regarding Emergent BioSolutions Inc. (EBS).